Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice
Irene Artuso, Mariateresa Pettinato, Antonella Nai, Alessia Pagani, Ugo Sardo, Benjamin Billoré, Maria Rosa Lidonnici, Cavan Bennett, Giacomo Mandelli, Sant-Rayn Pasricha, Giuliana Ferrari, Clara Camaschella, Léon Kautz, Laura Silvestri
Haematologica September 2018 : haematol.2018.199810; doi:10.3324/haematol.2018.199810

Author Affiliations

  1. Irene Artuso1,
  2. Mariateresa Pettinato2,
  3. Antonella Nai2,
  4. Alessia Pagani1,
  5. Ugo Sardo3,
  6. Benjamin Billoré3,
  7. Maria Rosa Lidonnici4,
  8. Cavan Bennett5,
  9. Giacomo Mandelli6,
  10. Sant-Rayn Pasricha7,
  11. Giuliana Ferrari6,
  12. Clara Camaschella8,
  13. Léon Kautz9 and
  14. Laura Silvestri2,*
  1. 1 IRCCS San Raffaele Scientific Institute, Milano, Italy;
  2. 2 IRCCS San Raffaele Scientific Institute & Vita-Salute San Raffaele University, Milano, Italy;
  3. 3 Université de Toulouse, INSERM U1220, INRA U1416, ENVT, UPS, Toulouse, France;
  4. 4 SR-Tiget Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy;
  5. 5 The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia;
  6. 6 SR-Tiget Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy;
  7. 7 The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia;
  8. 8 IRCCS San Raffaele Scientific Institute, Milan, Italy;
  9. 9 Université de Toulouse, INSERM U1220, Toulouse, France
  1. ↵* Corresponding author; email: silvestri.laura{at}hsr.it

Abstract

-

  • Received June 13, 2018.
  • Accepted September 27, 2018.
Back to top

Keywords

Iron Metabolism
BMP-SMAD pathway
H3K4me3
erythroferrone
hepcidin
Email
Citation Tools

Jump To

What about you?
Tell us your interests and get all the new contents of Haematologica in advance